Results 41 to 50 of about 29,501 (235)

Safety and efficacy of total thoracoscopic surgery for patients with tricuspid regurgitation and reduced right ventricular function after left heart valves replacement: a retrospective comparative study

BMC Cardiovascular Disorders, 2023
Background Tricuspid valve surgery is the standard treatment for tricuspid valve disease refractory to pharmacologic therapy. However, patients with tricuspid regurgitation after previous left heart valves replacement with reduced right ventricular (RV ...
Zhiqin Lin, Zheng Xu, Xiujun Chen, Feng Lin, Liangwan Chen, Xiaofu Dai   +5 more
doaj   +1 more source

Tricuspid valve surgery, review of the literature, M.D, Thesis

, 2022
The heart receives blood and pumps blood from and to the whole body. To do this, it has many parts: There are four chambers: the left atrium, left ventricle, the right atrium, the right ventricle, Four valves, the sinoatrial node (SA Node) and the ...
Souslian, Simon
core  

Reoperation for isolated rheumatic tricuspid regurgitation

Journal of Cardiothoracic Surgery, 2018
Background The reoperation for isolated tricuspid regurgitation in rheumatic population is rare and still unclear and controversial because of the rarity of publications.
Younes Moutakiallah, Mahdi Aithoussa, Noureddine Atmani, Aniss Seghrouchni, Azeddine Moujahid, Abdedaïm Hatim, Iliyasse Asfalou, Zouhair Lakhal, Abdelatif Boulahya   +8 more
doaj   +1 more source

Double valve replacement in a case of Hedinger syndrome

Clinical Case Reports, 2023
Hedinger Syndrome or carcinoid heart disease is a rare cardiac complication of neuroendocrine tumors (NET) affecting the tricuspid and pulmonary valves.
Presheet Pathare, Michael Weyand, Christian Heim   +2 more
doaj   +1 more source

Hemodynamics of transcatheter tricuspid valve replacement with Lux-Valve

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTranscatheter tricuspid valve intervention (TTVI) has emerged as an alternative treatment option for high-risk and inoperable patients with symptomatic tricuspid regurgitation (TR). However, scarce data in hemodynamic profiles were available on TTVI.
Wang Wei, Li Ning, Li Ning, Ning Xiaoping, Xu Zhiyun, Li Bailing, Cai Chengliang, Yang Fan, Zhou Guangwei, Bai Yifan, Han Lin, Qiao Fan, Lu Fanglin   +12 more
openaire   +3 more sources

Single Centre Experience With the Balloon‐Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow‐Up

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BAV) anatomy remains challenging due to anatomical complexity and limited trial data. New‐generation balloon‐expandable valves, such as Myval, require further evaluation in this subgroup.
Balázs Magyari, Bálint Kittka, Ilona Goják, Gábor Kasza, Kristóf Schönfeld, László Botond Szapáry, Mihály Simon, Rudolf Kiss, Andrea Bertalan, Edit Várady, István Szokodi, Iván Horváth   +11 more
wiley   +1 more source

Valve replacement for Ebstein’s anomaly of the tricuspid valve

The Journal of Thoracic and Cardiovascular Surgery, 1979
The role of valve replacement in the treatment of Ebstein's anomaly of the tricuspid valve remains controversial. Between 1965 and 1977, five patients with Ebstein's anomaly ranging in age from 11 to 57 years (mean 29) underwent tricuspid valve replacement in our institution. All of the patients were cyanotic but one, three were in Functional Class III,
E L, Bove, M M, Kirsh
openaire   +2 more sources

Cerebrovascular Events in Aortic Stenosis: From Native Valve Disease to TAVR‐Specific Risk and Prevention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger, Jamschid Sedighi, Martin Juenemann, Omar Alhaj‐Omar, Kerstin Piayda, Mani Arsalan, Samuel Sossalla, Won‐Keun Kim   +7 more
wiley   +1 more source

Tricuspid valve surgery for acute infective endocarditis can be performed with very low operative mortalityCentral MessagePerspective

JTCVS Open
Objective: Tricuspid valve surgery historically has been perceived as having elevated operative risk, prompting the recent development of transcatheter therapies including aspiration vegetectomy for endocarditis.
Ali Darehzereshki, MD, J. Hunter Mehaffey, MD, MSc, J.W. Awori Hayanga, MD, MPH, Lawrence Wei, MD, Taylor D'etcheverry, PA-C, Luigi F. Lagazzi, MD, Vinay Badhwar, MD   +6 more
doaj   +1 more source

Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis

, 2022
BACKGROUND: Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Miao, Lifu, Tang, Xiujie, Zhang, Mingkui, Xue, Hui, Xiujie Tang, Lifu Miao, Hui Xue, Yanbin Shao, Shao, Yanbin, Mingkui Zhang   +9 more
core   +1 more source